DOH: COVID-19 Drug Topics

Jackie Pappalardi and Lisa Volk in Clinical & Quality

The Department of Health today issued COVID-19 Drug Topics, which provides prescribers with an evidence-based, non-commercial source of the latest objective information about pharmaceuticals. The information is provided through our Prescriber Education Program (PEP), which is a partnership between the Department of Health and the State University of New York (SUNY) Medical and Pharmacy institutions.

Information regarding Colchicine, Hydroxychloroquine and Ibuprofen is now available on the COVID-19 Guidance for Medicaid Providers webpage.

Medicaid Redesign Team Updates
Office of Health Insurance Programs
New York State Department of Health
Albany, NY 12237 


Jackie Pappalardi, RN, BSN
Executive Director
518-462-4800 x16

Nancy Leveille, RN, MS
Director, Special Projects and Educational Development
518-462-4800 x20